Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 3/20 | 0.35 |
| ▸ | MLYCD | O95822 | 4/20 | 0.33 |
| ▸ | POLB | P06746 | 2/20 | 0.32 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.31 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.31 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27645545 | 0.89 | GSK3B (0.35) | GSK3BMLYCDPOLBNR1H4HPGD | |
| SCHEMBL4416120 | 0.88 | MLYCD (0.34) | GSK3BMLYCDNR1H4HPGDCA2 | |
| SCHEMBL480646 | 0.87 | ACHE (0.36) | GSK3BHPGDALDH1A1KMT2ALMNA | |
| SCHEMBL27625178 | 0.87 | MLYCD (0.36) | GSK3BMLYCDPOLBNR1H4HPGD | |
| SCHEMBL6019685 | 0.83 | THRA (0.35) | NR1H4KMT2ASMN1; SMN2CYP2C9MEN1 | |
| SCHEMBL6448136 | 0.82 | ESR1 (0.41) | MLYCDPOLBNR1H4HPGDALDH1A1 | |
| SCHEMBL10752558 | 0.82 | CYP2C9 (0.47) | POLBHPGDALDH1A1KMT2ALMNA | |
| SCHEMBL4418071 | 0.82 | CA2 (0.36) | GSK3BMLYCDNR1H4HPGDCA2 | |
| SCHEMBL4427192 | 0.78 | RARA (0.35) | MLYCDALDH1A1KMT2ATSHRMEN1 | |
| SCHEMBL4421929 | 0.77 | ALDH1A1 (0.48) | HPGDALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2411359-B1 | NOVEL OLIGOFUNCTIONAL PHOTOINITIATORS | BASF SE (DE) | 2017-02-01 | — | — | EP | disclosed |
| EP-2411359-B1 | NOVEL OLIGOFUNCTIONAL PHOTOINITIATORS | BASF SE (DE) | 2017-02-01 | — | — | EP | disclosed |
| US-8604251-B2 | Oligofunctional photoinitiators | BASF SE (DE) | 2013-12-10 | — | — | US | disclosed |
| US-20120029107-A1 | NOVEL OLIGOFUNCTIONAL PHOTOINITIATORS | BASF SE (DE) | 2012-02-02 | — | — | US | disclosed |
| US-20120029107-A1 | NOVEL OLIGOFUNCTIONAL PHOTOINITIATORS | BASF SE (DE) | 2012-02-02 | — | — | US | disclosed |
| EP-2411359-A1 | NOVEL OLIGOFUNCTIONAL PHOTOINITIATORS | BASF SE (DE) | 2012-02-01 | — | — | EP | disclosed |
| WO-2010108862-A1 | NOVEL OLIGOFUNCTIONAL PHOTOINITIATORS | BASF SE (DE) | 2010-09-30 | — | — | WO | disclosed |
| EP-1620475-B1 | NOVEL TRIFUNCTIONAL PHOTOINITIATORS | BASF SE (DE) | 2009-11-11 | — | — | EP | disclosed |
| EP-1620475-B1 | NOVEL TRIFUNCTIONAL PHOTOINITIATORS | BASF SE (DE) | 2009-11-11 | — | — | EP | disclosed |
| US-7462650-B2 | Trifunctional photoinitiators | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2008-12-09 | — | — | US | disclosed |
| US-7462650-B2 | Trifunctional photoinitiators | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2008-12-09 | — | — | US | disclosed |
| US-7462650-B2 | Trifunctional photoinitiators | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2008-12-09 | — | — | US | disclosed |
| US-20060270748-A1 | Novel trifunctional photoinitiators | IGM GROUP B.V. (NL) | 2006-11-30 | — | — | US | disclosed |
| EP-1620475-A1 | NOVEL TRIFUNCTIONAL PHOTOINITIATORS | Ciba SC Holding AG (CH) | 2006-02-01 | — | — | EP | disclosed |
| WO-2004099262-A1 | NOVEL TRIFUNCTIONAL PHOTOINITIATORS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2004-11-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120029107-A1 | NOVEL OLIGOFUNCTIONAL PHOTOINITIATORS | CCNA1, CCNT1, TET1 | GSK3B 2509/4885MLYCD 4663/4885POLB 537/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.